NFLPA Demands Investigation into Jalen Hurts' Medical Care

The NFL Players Association (NFLPA) has formally requested a comprehensive investigation into the medical treatment provided to Philadelphia Eagles quarterback Jalen Hurts following his diagnosis with multiple blood clots in his lungs. The condition ultimately ended Hurts' season.

Hurts was initially diagnosed with a superficial vein thrombosis in his left calf after sustaining an injury from a cleat during a game against the Los Angeles Rams. He subsequently played in a game in London the following week against the Jacksonville Jaguars. Reports indicate Hurts played after spending the night in a hospital until 4 a.m. before the London game and then flying back to the United States. He was later placed on injured reserve, missing the Eagles' subsequent game against the Carolina Panthers.

Further medical evaluations revealed the diagnosis to be a deep vein thrombosis (DVT) along with bilateral pulmonary emboli.

In a statement, the NFLPA expressed concern over the handling of Hurts' injury, noting that the league had previously informed the union that it did not plan to review the care provided. "Before conclusions are drawn about how this situation was handled, there must be a full investigation into what occurred," the NFLPA stated. "Determining the facts is essential to ensuring players receive the highest level of care and protection going forward."

The NFL, however, has defended the Eagles' medical staff and the decision-making process. Dr. Allen Sills, the NFL's Chief Medical Officer, dismissed speculation about external factors or physicians disregarding player safety. "The notion that there are external factors or that any of our physicians would put a player in harm’s way - that's nonsense," Sills said. He asserted that all actions were taken with the patient's best interests at heart and expressed confidence in the Eagles' medical team, describing their approach as "very conservative, very patient-focused and appropriately guarded at every step."

Jeff Miller, the NFL's executive vice president overseeing player health and safety, echoed these sentiments, stating that Jalen Hurts' health was consistently prioritized. Miller characterized reporting on the matter as containing "considerable and uninformed speculation."

Eagles head coach Nick Sirianni also voiced his support for the team's medical staff, stating he has "full trust and full faith in them" and that player health is always paramount.

Hurts' ongoing treatment involves blood thinners, and he is barred from participating in any football activities until he is cleared off this medication. The Eagles organization confirmed on Monday that Hurts is "clinically stable and has no significant functional limitations."